The stock of Sesen Bio Inc. (NASDAQ:SESN) decreased by $0.0 on Wednesday to $0.54, down -0.02 percent. The last five days have seen an average of 792,748 shares of common stock traded. 5 times new highs were reached in the current year, with a fall of -$0.2750. The average number of shares traded over the last 20 days was 730,737, while the average volume over the last 50 days totaled 1,095,927.
SESN stock appreciated 8.30% since last month. On 10/24/22, the company’s shares reached a one-month low of $0.4700. The stock touched a high of $1.14 on 07/14/22, after rallying from a low of $0.37 in 52 weeks. The price of SESN stock has declined by -33.74% or -$0.2750 this year, reaching a new high 5 times. Still, the stock price is down -52.64% from the 52-week high.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
Beta for the stock is 0.99. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.83, the price-to-book (PB) ratio of 0.66.
For the three months ended September 29, Sesen Bio Inc.’s quick ratio was 5.50, while its current ratio was 5.50, indicating its ability to pay off its debt. Sesen Bio Inc.’s operating margin stood at -29.80% for the same period. Based on annual data, it had gross profit of $35.09 million and revenue of $26.54 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. SESN’s return on assets (ROA) during the last 12 months has been -6.20%. There was a -0.20% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -8.00%.
According to Sesen Bio Inc.’s quarterly financial report for the quarter that ended September 29, it had $106.43 million in cash and short-term investments. It was predicted that Sesen Bio Inc.’s quarterly earnings would be $0.1, but it ended up being -$0.15, beating the consensus by 166.70%. EBITDA was $19.78 million for the quarter. Equity owned by shareholders amounts to $202.76 million.
Here’s a quick look at Sesen Bio Inc.’s (SESN) price momentum from a technical perspective. As of 22 November, the RSI 9-day stood at 44.88%, suggesting the stock is Neutral, with a 24.74% historical volatility rate.
The stochastic %K and %D were 55.18% and 66.78% respectively, while the average true range (ATR) was 0.0345. Based on the 14-day stochastic reading of 49.69%, the RSI (14) reading is 49.13%. On the 9-day MACD Oscillator, the stock is at -0.0088.
Sesen Bio Inc. (NASDAQ: SESN) was downgraded by H.C. Wainwright to a a Neutral rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Sesen Bio Inc. (SESN) an Hold rating. SESN is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 0 others recommend it as a buy.
What is SESN’s price target for the next 12 months?
The current consensus forecast for the stock is between $0.60 and $0.60, with a median target price of $0.60. In analyzing these forecasts, the average price target given by analysts for Sesen Bio Inc. (SESN) is $0.60.